![TOGA Podcast artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts124/v4/cb/1c/aa/cb1caabd-3426-78c1-9e3f-91606c3249c2/mza_5100909129334403906.jpg/100x100bb.jpg)
Operability in Stage III NSCLC
TOGA Podcast
English - July 04, 2023 14:00 - 31 minutes - 28.6 MBMedicine Health & Fitness lung cancer oncology toga Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: NSCLC and KRAS Mutations
In this TOGA Podcast, we discuss what defines operability in locally advanced stage III NSCLC. A/Professor Tim Clay, Medical Oncologist from St John of God Subiaco and Rockingham General is joined by Professor Lucy Morgan, Board Chair of the Lung Foundation of Australia and Respiratory Physician from Concord & Nepean Hospitals; A/Professor Phillip Antippa, Cardiothoracic surgeon and the Head of Thoracic Surgical Services at the Royal Melbourne Hospital and the VCCC and also Dr Qurrat van den Blink, Radiation Oncologist from GenesisCare based in Perth (Joondalup) and Albany.